• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

趋化素在特发性肺纤维化中的表达及其保护作用研究

Expression and protective effect of chemerin in idiopathic pulmonary fibrosis

摘要目的:探讨趋化素在特发性肺纤维化(IPF)中的表达及其作用。方法:分别使用定量PCR与蛋白质免疫印迹法测定对照与IPF患者肺部组织中趋化素的mRNA及蛋白表达水平,通过酶联免疫吸附实验检测临床血清样本中趋化素的含量。构建肺纤维化体外模型,将分离得到的原代成纤维细胞分成对照组、TGF-β组、TGF-β+趋化素组和趋化素组,使用免疫荧光法检测各组成纤维细胞α-平滑肌蛋白(α-SMA)表达水平。构建肺纤维化体内模型,采用随机分组法将C57BL/6小鼠分成对照组、博来霉素组、博来霉素+趋化素组和趋化素组,通过肺组织病理学染色观察各组小鼠肺纤维化严重程度。通过定量PCR与免疫组化染色法分别检测肺纤维化体外与体内模型中上皮间充质转化(EMT)标记基因的表达情况。结果:与对照组相比,IPF患者肺组织与血清中趋化素表达量均下调。免疫荧光结果显示,TGF-β组α-SMA表达水平较对照组明显增强,TGF-β+趋化素组中α-SMA表达水平则与对照组相仿。病理学染色结果显示,博来霉素组小鼠较对照组肺组织纤维化病变明显,趋化素表达量显著下调;博来霉素+趋化素组小鼠肺组织受损程度则有所缓解。定量PCR与免疫组化结果显示,趋化素在A549细胞与小鼠肺组织中分别减弱了由TGF-β与博来霉素诱导的EMT作用。结论:趋化素在IPF患者中表达降低;趋化素可能通过调控EMT而在肺纤维化的发生中发挥保护作用。

更多

abstractsObjective:To explore the expression and the role of chemerin in idiopathic pulmonary fibrosis (IPF).Methods:Quantitative PCR and Western blotting were used to determine the mRNA and protein levels of chemerin in lung tissues from IPF patients and the controls. Clinical serum level of chemerin was analyzed by enzyme-linked immunosorbent assay. The mouse lung fibroblasts isolated and cultured in vitro were divided into the control, TGF-β, TGF-β+chemerin and chemerin groups. Immunofluorescence staining was used to observe the expression of α-smooth muscle actin (α-SMA). C57BL/6 mice were randomly divided into the control, bleomycin, bleomycin+chemerin, and chemerin groups. Masson and immunohistochemical staining were performed to evaluate the severity of pulmonary fibrosis. Expression of epithelial to mesenchymal transition (EMT) markers was detected by quantitative PCR and immunohistochemical staining in the in vitro and in vivo models of pulmonary fibrosis, respectively. Results:Compared with the control group, the expression of chemerin was downregulated in both the lung tissue and the serum of IPF patients. Immunofluorescence showed that treatment of fibroblasts with TGF-β alone resulted in a robust expression of α-SMA, whereas treatment with TGF-β and chemerin together exhibited the similar expression levels of α-SMA as the control group. Masson staining indicated that the bleomycin-induced pulmonary fibrosis model was constructed successfully, while treatment of chemerin partially alleviated the damage of lung tissue. Immunohistochemical staining showed that the expression of chemerin in the lung tissue was significantly decreased in the bleomycin group. Quantitative PCR and immunohistochemistry showed that chemerin attenuated EMT induced by TGF-β and bleomycin both in vitro and in vivo. Conclusions:The expression of chemerin was reduced in patients with IPF. Chemerin may play a protective role in the development of IPF by regulating EMT, providing a new idea for the clinical treatment of IPF.

More
广告
  • 浏览48
  • 下载0
中华结核和呼吸杂志

中华结核和呼吸杂志

2023年46卷7期

688-696页

MEDLINEISTICPKUCSCD

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷